Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent research progress in hepatocellular carcinoma.

Jia-Horng Kao1, Ding-Shinn Chen

  • 1Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei,Taiwan.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|July 10, 2002
PubMed
Summary

Hepatocellular carcinoma (HCC), a global health concern, is linked to viral infections like hepatitis B and C. Understanding its genetic pathways and improving treatment strategies are crucial for managing this challenging liver cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function.

Hepatology (Baltimore, Md.)·2022
Same author

Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants.

Hepatology (Baltimore, Md.)·2021
Same author

Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters.

JHEP reports : innovation in hepatology·2021
Same author

The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2021
Same author

Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi·2020
Same author

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.

Scientific reports·2020

Area of Science:

  • Hepatology
  • Oncology
  • Viral Hepatitis

Background:

  • Hepatocellular carcinoma (HCC) poses a significant global health burden, with incidence rates rising due to viral infections.
  • Hepatitis B and C virus infections are major risk factors, though oncogenic pathways remain unclear.
  • Current HCC management is challenging due to a lack of robust clinical trials and a high proportion of unresectable tumors.

Purpose of the Study:

  • To review the current understanding of hepatocellular carcinoma (HCC).
  • To explore etiologic factors, genetic mechanisms, diagnosis, therapy, and prevention of HCC.
  • To highlight the need for further research into molecular features for innovative management strategies.

Main Methods:

  • Literature review of existing studies on HCC.

Related Experiment Videos

  • Analysis of data on viral risk factors and their impact on HCC incidence.
  • Examination of current diagnostic and therapeutic approaches for HCC.

    • Main Results:

    • Hepatitis B vaccination has reduced HCC incidence in children, while Hepatitis C is increasing HCC rates globally.
    • Genetic and molecular mechanisms underlying hepatocarcinogenesis require further elucidation.
    • Existing treatments like surgery and ablation have limitations, especially for advanced HCC.

    Conclusions:

    • Elucidating the genetic and molecular features of HCC is essential for developing novel therapeutic strategies.
    • Improved diagnostic tools and well-designed clinical trials are needed to refine HCC management.
    • Prevention through vaccination and understanding risk factors remains critical for controlling HCC globally.